FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
Abstract Background Targeted therapy is an effective strategy for the treatment of advanced and metastatic pancreatic cancer, one of the leading causes for cancer-related death worldwide. To address the limitations of existing targeted drugs, there is an urgently need to find novel targets and thera...
Saved in:
| Main Authors: | Xiaolong Liu, Xueyan Zhang, Tingyu Zeng, Yali Chen, Liu Ye, Shuping Wang, Yulan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06304-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Noncoding RNAs as regulators of FOSL1 in cancer
by: Xiaochang Wang, et al.
Published: (2025-08-01) -
FOSL1 promotes keratinocyte migration and wound repair by modulating the IL17 signaling pathway
by: Haoran Mao, et al.
Published: (2025-05-01) -
Single-Cell Transcriptomics Unveils the Mechanistic Role of FOSL1 in Cutaneous Wound Healing
by: Jingbi Meng, et al.
Published: (2025-05-01) -
TRIM21 functions as an oncogene in glioblastoma by transactivating FOSL1 and promoting the ubiquitination of p27
by: Vanajothi Ramar, et al.
Published: (2025-07-01) -
Transcription Factor FOSL1 Promotes Cisplatin Resistance in Non-Small Cell Lung Cancer Cells by Modulating the Wnt3a/β-Catenin Signaling through Upregulation of PLIN3 Expression
by: Wanning Tong, et al.
Published: (2025-03-01)